Primary |
Hypercholesterolaemia |
18.7% |
Product Used For Unknown Indication |
11.0% |
Systemic Lupus Erythematosus |
11.0% |
Hypertension |
6.6% |
Abortion Induced |
4.4% |
Dyslipidaemia |
4.4% |
Hyperlipidaemia |
4.4% |
Nephrotic Syndrome |
4.4% |
Pain |
4.4% |
Type 2 Diabetes Mellitus |
4.4% |
Vena Cava Thrombosis |
4.4% |
Atrial Fibrillation |
3.3% |
Infarction |
3.3% |
Abdominal Pain Upper |
2.2% |
Asthma |
2.2% |
Blood Cholesterol |
2.2% |
Blood Cholesterol Increased |
2.2% |
Essential Hypertension |
2.2% |
Gastritis Prophylaxis |
2.2% |
Muscle Spasms |
2.2% |
|
Rhabdomyolysis |
20.0% |
Hepatitis |
6.7% |
Renal Failure Acute |
6.7% |
Tendon Rupture |
6.7% |
Ventricular Septal Defect |
6.7% |
Wrong Technique In Drug Usage Process |
6.7% |
Breast Cancer |
3.3% |
Colitis Microscopic |
3.3% |
Convulsion |
3.3% |
Dry Mouth |
3.3% |
Epilepsy |
3.3% |
Eyelid Oedema |
3.3% |
Glioblastoma |
3.3% |
Haematuria |
3.3% |
Heart Valve Operation |
3.3% |
Helicobacter Infection |
3.3% |
Hepatocellular Injury |
3.3% |
Hodgkin's Disease |
3.3% |
Hypertransaminasaemia |
3.3% |
Idiopathic Thrombocytopenic Purpura |
3.3% |
|
Secondary |
Product Used For Unknown Indication |
30.4% |
Drug Use For Unknown Indication |
17.1% |
Hypercholesterolaemia |
11.1% |
Myocardial Infarction |
4.3% |
Hyperlipidaemia |
4.1% |
Systemic Lupus Erythematosus |
4.1% |
Pain |
3.8% |
Hypertension |
3.3% |
Myalgia |
2.7% |
Abdominal Pain Upper |
2.4% |
Post-anoxic Myoclonus |
2.4% |
Blood Cholesterol Increased |
2.2% |
Dyslipidaemia |
2.2% |
Type 2 Diabetes Mellitus |
1.9% |
Muscle Spasms |
1.6% |
Nephrotic Syndrome |
1.6% |
Asthma |
1.4% |
Atrial Fibrillation |
1.1% |
Cramps |
1.1% |
Muscle Pain |
1.1% |
|
Rhabdomyolysis |
21.5% |
Musculoskeletal Discomfort |
9.2% |
Hepatocellular Injury |
6.2% |
Ventricular Septal Defect |
6.2% |
Aphthous Stomatitis |
4.6% |
Hepatic Necrosis |
4.6% |
Myalgia |
4.6% |
Pancreatitis Acute |
4.6% |
Primary Hypogonadism |
4.6% |
Pyrexia |
4.6% |
Amyotrophic Lateral Sclerosis |
3.1% |
Drug Interaction |
3.1% |
Hypertension |
3.1% |
Pancreatitis |
3.1% |
Polyneuropathy |
3.1% |
Renal Failure Acute |
3.1% |
Thinking Abnormal |
3.1% |
Toxic Skin Eruption |
3.1% |
Visual Impairment |
3.1% |
Colitis Microscopic |
1.5% |
|
Concomitant |
Drug Use For Unknown Indication |
38.0% |
Hypertension |
13.0% |
Product Used For Unknown Indication |
10.6% |
Blood Cholesterol Increased |
4.7% |
Rheumatoid Arthritis |
4.5% |
Diabetes Mellitus |
4.1% |
Hypercholesterolaemia |
3.3% |
Type 2 Diabetes Mellitus |
2.7% |
Prophylaxis |
2.6% |
Blood Cholesterol |
2.3% |
Depression |
2.1% |
Vitamin Supplementation |
1.8% |
Atrial Fibrillation |
1.6% |
Coronary Artery Disease |
1.5% |
Hyperlipidaemia |
1.4% |
Osteoporosis |
1.3% |
Gastrooesophageal Reflux Disease |
1.2% |
Thrombosis Prophylaxis |
1.2% |
Crohn's Disease |
1.1% |
Dyslipidaemia |
1.1% |
|
Flushing |
12.6% |
Pruritus |
8.8% |
Renal Failure Acute |
8.2% |
Paraesthesia |
7.1% |
Vomiting |
6.6% |
Renal Failure |
6.0% |
Bone Marrow Failure |
4.4% |
Nausea |
4.4% |
Somnolence |
4.4% |
Tremor |
4.4% |
Hyperhidrosis |
3.8% |
Cerebrovascular Accident |
3.3% |
Hyponatraemia |
3.3% |
Myocardial Infarction |
3.3% |
Pain In Extremity |
3.3% |
Pyrexia |
3.3% |
Skin Burning Sensation |
3.3% |
Visual Impairment |
3.3% |
Wound |
3.3% |
Accidental Exposure |
2.7% |
|
Interacting |
Schizoaffective Disorder |
18.6% |
Cardiovascular Event Prophylaxis |
9.3% |
Depression |
9.3% |
Hypercholesterolaemia |
9.3% |
Hyperlipidaemia |
9.3% |
Myocardial Infarction |
9.3% |
Hiv Infection |
7.0% |
Renal Transplant |
7.0% |
Vitamin Supplementation |
4.7% |
Angina Pectoris |
2.3% |
Blood Cholesterol |
2.3% |
Blood Cholesterol Abnormal |
2.3% |
Hypertension |
2.3% |
Mineral Supplementation |
2.3% |
Osteoporosis |
2.3% |
Pain |
2.3% |
|
Drug Interaction |
33.3% |
Hypomania |
22.2% |
Respiratory Failure |
11.1% |
Rhabdomyolysis |
11.1% |
Tremor |
11.1% |
Vomiting |
11.1% |
|